Quest Partners LLC Grows Stake in Exponent, Inc. (NASDAQ:EXPO)

Quest Partners LLC lifted its holdings in shares of Exponent, Inc. (NASDAQ:EXPOFree Report) by 725.5% during the 3rd quarter, Holdings Channel.com reports. The fund owned 15,396 shares of the business services provider’s stock after buying an additional 13,531 shares during the period. Quest Partners LLC’s holdings in Exponent were worth $1,775,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Quarry LP purchased a new position in Exponent in the second quarter valued at approximately $25,000. GAMMA Investing LLC boosted its holdings in shares of Exponent by 67.7% in the 2nd quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock valued at $36,000 after buying an additional 153 shares in the last quarter. Whittier Trust Co. of Nevada Inc. grew its position in shares of Exponent by 166.5% in the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after buying an additional 323 shares during the last quarter. USA Financial Formulas acquired a new stake in Exponent during the 3rd quarter worth $60,000. Finally, Benjamin F. Edwards & Company Inc. lifted its position in Exponent by 70.5% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider’s stock valued at $83,000 after acquiring an additional 361 shares during the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Insiders Place Their Bets

In related news, Director Paul R. Johnston sold 14,000 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the transaction, the director now owns 80,742 shares of the company’s stock, valued at $8,445,613.20. This trade represents a 14.78 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Carol Lindstrom sold 1,039 shares of the business’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the completion of the transaction, the director now owns 5,871 shares in the company, valued at $565,494.72. This trade represents a 15.04 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 29,039 shares of company stock valued at $2,979,526. Insiders own 2.10% of the company’s stock.

Exponent Trading Down 1.4 %

Shares of NASDAQ EXPO opened at $96.01 on Tuesday. The stock has a market cap of $4.87 billion, a P/E ratio of 46.38 and a beta of 0.69. The stock has a 50 day moving average of $107.07 and a two-hundred day moving average of $102.14. Exponent, Inc. has a twelve month low of $68.70 and a twelve month high of $115.75.

Exponent Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be paid a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date of this dividend is Friday, December 6th. Exponent’s dividend payout ratio is currently 54.11%.

Analysts Set New Price Targets

Separately, Truist Financial reaffirmed a “buy” rating and set a $120.00 price objective (up previously from $100.00) on shares of Exponent in a report on Friday, July 26th.

View Our Latest Report on Exponent

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Articles

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.